Abstract
Introduction: Fever and neutropenia are common clinical manifestations at the onset of pediatric acute lymphoblastic leukemia (ALL). This study aimed to describe the clinical and microbiological characteristics and outcomes of pediatric patients with ALL presenting with febrile neutropenia (FN) as the initial manifestation. Materials and methods: This retrospective study included children with ALL and FN within 72 h of diagnosis, prior to treatment. A descriptive analysis of the clinical and laboratory data was performed. Results: Over 10 years, 134 (24%) patients with ALL presented with FN initially. Empiric broad-spectrum antibiotics were administered to 91% (122/134) of the patients. Blood cultures identified pathogens in 4.1% (5/122) of the patients FN-related complications occurred in 7.4% (10/134); no mortality was recorded. Discussion: FN was the initial manifestation of ALL. Management followed chemotherapy-associated FN guidelines; however, microbiological isolates, resistance patterns, and complications differed significantly from those of chemotherapy-induced FN. In conclusion, further studies are needed to characterize FN at ALL diagnosis and establish optimal management guidelines for non-chemotherapy-associated FN.